Actionable news
All posts from Actionable news
Actionable news in ZGNX: Zogenix, Inc.,

William Blair Remains Sidelined on Zogenix, Inc. Following 3Q:15 Update

In a research report released today, William Blair analyst Tim Lugo reiterated a Market Perform rating on shares of Zogenix, Inc. (NASDAQ:ZGNX), after the company reported third-quarter earnings and gave a corporate update In trading Tuesday the shares shot up to 10.83% to close at $13.20.

Lugo wrote, “The company continues to prepare for the guided initiation of its Phase III program with ZX008, the company’s lead candidate to treat Dravet syndrome, in fourth quarter 2015. Zogenix submitted the investigational new drug (IND) application at the end of August and subsequently announced...